Reply to Caccialanza et al
Am J Clin Nutr
.
2021 Apr 6;113(4):1054-1055.
doi: 10.1093/ajcn/nqaa425.
Authors
Pierre Boisselier
1
,
Simon Thézénas
2
,
Nicolas Flori
3
,
Marie Vinches
4
,
Jean Bourhis
5
,
Pierre Senesse
3
6
Affiliations
1
From the Radiotherapy Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
2
Biometrics Unit, Montpellier Cancer Institute (ICM), University of Montpellier, France.
3
Clinical Nutrition and Gastroenterology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
4
Oncology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
5
Department of Radiotherapy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
6
IRCM, University of Montpellier, INSERM, ICM, Montpellier, France.
PMID:
33822866
DOI:
10.1093/ajcn/nqaa425
No abstract available
Publication types
Comment
MeSH terms
Chemoradiotherapy, Adjuvant*
Double-Blind Method
Head and Neck Neoplasms*
Humans